CollPlant Secures $2.6M Private Placement, Issuing Millions of Shares and Warrants at Discount
CLGN sits 33% above its 52-week low of $0.271.
Summary
CollPlant Biotechnologies announced a $2.6 million private placement, issuing 7.6 million ordinary shares and warrants for an additional 23 million shares at $0.34 per share. This financing is critical for the company, which has a market cap of only $5.28 million, but it comes with significant dilution. The raise follows a series of negative events, including the termination of a key development agreement, a 50% workforce reduction, extremely poor Q1 results, and a 'going concern' warning. The capital infusion is necessary for working capital and R&D, highlighting the company's ongoing financial distress.
At the time of this announcement, CLGN was trading at $0.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $0.27 to $3.23. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.